Overview
Jonas Heitmann practices practicing medicine in Tuebingen, Germany.
Mr. Heitmann is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Leukemia, Chronic Lymphocytic Leukemia (CLL), and Chronic B-Cell Leukemia (CBCL).
He is actively involved in clinical research, co-authoring 73 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jonas S. Heitmann
Is Jonas S. Heitmann a top-rated expert for Fibrolamellar Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Jonas S. Heitmann is classified as an Distinguished expert for Fibrolamellar Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jonas S. Heitmann participate in research or clinical trials?
Yes. Jonas S. Heitmann has published 73 articles and abstracts on conditions like Fibrolamellar Carcinoma. You can view a list of Jonas S. Heitmann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Fibrolamellar CarcinomaMr. Heitmann isDistinguished. Learn about Fibrolamellar Carcinoma.
- Advanced
- Acute Myeloid Leukemia (AML)Mr. Heitmann isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Chronic B-Cell Leukemia (CBCL)Mr. Heitmann isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Heitmann isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- LeukemiaMr. Heitmann isAdvanced. Learn about Leukemia.
- Small Lymphocytic Lymphoma (SLL)Mr. Heitmann isAdvanced. Learn about Small Lymphocytic Lymphoma (SLL).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Heitmann isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Chronic Myelogenous Leukemia (CML)Mr. Heitmann isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- COVID-19Mr. Heitmann isExperienced. Learn about COVID-19.
- Liver CancerMr. Heitmann isExperienced. Learn about Liver Cancer.
- Long Haul COVIDMr. Heitmann isExperienced. Learn about Long Haul COVID.
- Prostate CancerMr. Heitmann isExperienced. Learn about Prostate Cancer.
- Rosai-Dorfman DiseaseMr. Heitmann isExperienced. Learn about Rosai-Dorfman Disease.
- Severe Acute Respiratory Syndrome (SARS)Mr. Heitmann isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).